Selenium, Zinc, and Plasma Total Antioxidant Status and the Risk of Colorectal Adenoma and Cancer

Overview

Journal Metabolites

Publisher MDPI

Date 2024 Sep 27

PMID 39330493

Authors

Miloslawa Zowczak-Drabarczyk

Jacek Bialecki

Teresa Grzelak

Mikolaj Michalik

Dorota Formanowicz

Affiliations

Soon will be listed here.

Abstract

Selenium (Se), zinc (Zn), and copper (Cu) are known to be involved in carcinogenesis and participate in the defence against reactive oxygen species (ROS). This study aimed to evaluate the clinical utility of serum Se, Zn, and Cu concentrations and plasma total antioxidant status (TAS) in the diagnosis of colorectal cancer (CRC) and colorectal adenoma (CRA) in a population of low Se and borderline Zn status. Based on clinical examination and colonoscopy/histopathology, the patients (n = 79) were divided into three groups: colorectal cancer (n = 30), colorectal adenoma (n = 19), and controls (CONTROL, n = 30). The serum Se concentration was lower in the CRC group than in the CRA group (by 9.1%, < 0.0001) and the CONTROL group (by 7.9%, < 0.0001). In turn, the serum Zn concentration was decreased in the CRA group (by 17.9%, = 0.019) when compared to the CONTROL group. Plasma TAS was lower in the CRC group (by 27.8%, = 0.017) than in the CONTROL group. In turn, the serum Zn concentration was decreased in the CRA group when compared to the CONTROL group. Plasma TAS was lower in the CRC group than in the CONTROL group. ROC (receiver operating characteristic) curve analysis revealed that the Se level was of the highest diagnostic utility for the discrimination of the CRC group from both the CRA group (area under ROC curve (AUC) 0.958, sensitivity 84.21%, specificity 100%) and the CONTROL group (AUC 0.873, sensitivity 100%, specificity 66.67%). The Zn and TAS levels were significantly accurate in the differentiation between the groups. An individualised risk of colorectal adenoma and cancer approach could comprise Se, Zn, and TAS assays in the population.

References

Lv S, Ding Y, Huang J, He Y, Xie R, Shi X . Genetic prediction of micronutrient levels and the risk of colorectal polyps: A mendelian randomization study. Clin Nutr. 2024; 43(6):1405-1413. DOI: 10.1016/j.clnu.2024.04.019. View

Han J, Luo J, Wang C, Kapilevich L, Zhang X . Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases. Biomed Pharmacother. 2024; 174:116570. DOI: 10.1016/j.biopha.2024.116570. View

Jiang J, Chen B, Tang B, Wei Q . Selenium in Prostate Cancer: Prevention, Progression, and Treatment. Pharmaceuticals (Basel). 2023; 16(9). PMC: 10536940. DOI: 10.3390/ph16091250. View

Zowczak M, Iskra M, Paszkowski J, Manczak M, Torlinski L, Wysocka E . Oxidase activity of ceruloplasmin and concentrations of copper and zinc in serum of cancer patients. J Trace Elem Med Biol. 2002; 15(2-3):193-6. DOI: 10.1016/S0946-672X(01)80066-3. View

Zinczuk J, Maciejczyk M, Zareba K, Romaniuk W, Markowski A, Kedra B . Antioxidant Barrier, Redox Status, and Oxidative Damage to Biomolecules in Patients with Colorectal Cancer. Can Malondialdehyde and Catalase Be Markers of Colorectal Cancer Advancement?. Biomolecules. 2019; 9(10). PMC: 6843197. DOI: 10.3390/biom9100637. View

Cai X, Su Y, Ning J, Fan X, Shen M . Research on the Effect and Mechanism of Selenium on Colorectal Cancer Through TRIM32. Biol Trace Elem Res. 2024; 203(2):670-683. DOI: 10.1007/s12011-024-04206-4. View

Speckmann B, Grune T . Epigenetic effects of selenium and their implications for health. Epigenetics. 2015; 10(3):179-90. PMC: 4623467. DOI: 10.1080/15592294.2015.1013792. View

Hara A, Sasazuki S, Inoue M, Iwasaki M, Shimazu T, Sawada N . Zinc and heme iron intakes and risk of colorectal cancer: a population-based prospective cohort study in Japan. Am J Clin Nutr. 2012; 96(4):864-73. DOI: 10.3945/ajcn.112.041202. View

Al-Ansari R, Al-Gebori A, Sulaiman G . Serum levels of zinc, copper, selenium and glutathione peroxidase in the different groups of colorectal cancer patients. Caspian J Intern Med. 2021; 11(4):384-390. PMC: 7911763. DOI: 10.22088/cjim.11.4.384. View

10.

Gopcevic K, Rovcanin B, Tatic S, Krivokapic Z, Gajic M, Dragutinovic V . Activity of superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase in different stages of colorectal carcinoma. Dig Dis Sci. 2013; 58(9):2646-52. DOI: 10.1007/s10620-013-2681-2. View

11.

Wan Y, Zhang B . The Impact of Zinc and Zinc Homeostasis on the Intestinal Mucosal Barrier and Intestinal Diseases. Biomolecules. 2022; 12(7). PMC: 9313088. DOI: 10.3390/biom12070900. View

12.

Gupta S, Shukla V, VAIDYA M, Roy S, Gupta S . Serum and tissue trace elements in colorectal cancer. J Surg Oncol. 1993; 52(3):172-5. DOI: 10.1002/jso.2930520311. View

13.

Wang D, Wang K, Yan D, Liu J, Wang B, Li M . Ciz1 is a novel predictor of survival in human colon cancer. Exp Biol Med (Maywood). 2014; 239(7):862-870. DOI: 10.1177/1535370213520113. View

14.

Li Y, Browne R, Bonner M, Deng F, Tian L, Mu L . Positive relationship between total antioxidant status and chemokines observed in adults. Oxid Med Cell Longev. 2014; 2014:693680. PMC: 4164799. DOI: 10.1155/2014/693680. View

15.

La Vecchia C, Decarli A, Serafini M, Parpinel M, Bellocco R, Galeone C . Dietary total antioxidant capacity and colorectal cancer: a large case-control study in Italy. Int J Cancer. 2013; 133(6):1447-51. DOI: 10.1002/ijc.28133. View

16.

Gumulec J, Masarik M, Adam V, Eckschlager T, Provaznik I, Kizek R . Serum and tissue zinc in epithelial malignancies: a meta-analysis. PLoS One. 2014; 9(6):e99790. PMC: 4062461. DOI: 10.1371/journal.pone.0099790. View

17.

Sorribes Carreras P, Torres Feced P . [Zinc intake deficiency and colorectal cancer: what is the situation in our population?]. Nutr Hosp. 2000; 15(4):153-5. View

18.

Kucharzewski M, Braziewicz J, Majewska U, Gozdz S . Selenium, copper, and zinc concentrations in intestinal cancer tissue and in colon and rectum polyps. Biol Trace Elem Res. 2003; 92(1):1-10. DOI: 10.1385/BTER:92:1:1. View

19.

Ejtehadi F, Taghavi A, Ejtehadi F, Shahramian I, Niknam R, Moini M . Prevalence of Colonic Polyps Detected by Colonoscopy in Symptomatic Patients and Comparison Between Different Age Groups. What Age Should be Considered for Investigation?. Pol Przegl Chir. 2024; 96(1):15-21. DOI: 10.5604/01.3001.0053.3997. View

20.

Urnov F, Rebar E, Holmes M, Zhang H, Gregory P . Genome editing with engineered zinc finger nucleases. Nat Rev Genet. 2010; 11(9):636-46. DOI: 10.1038/nrg2842. View